Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.8.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2018
May 11, 2018
Document And Entity Information    
Entity Registrant Name Monopar Therapeutics  
Entity Central Index Key 0001645469  
Document Type 10-Q  
Document Period End Date Mar. 31, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? No  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   9,291,421
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2018